Cue Biopharma Inc (CUE)
1.05
+0.02
(+1.94%)
USD |
NASDAQ |
Nov 22, 16:00
1.05
0.00 (0.00%)
After-Hours: 20:00
Cue Biopharma Shareholders Equity (Quarterly): 25.37M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 25.37M |
| June 30, 2024 | 21.62M |
| March 31, 2024 | 30.04M |
| December 31, 2023 | 37.08M |
| September 30, 2023 | 42.67M |
| June 30, 2023 | 46.00M |
| March 31, 2023 | 55.02M |
| December 31, 2022 | 65.68M |
| September 30, 2022 | 50.76M |
| June 30, 2022 | 59.76M |
| March 31, 2022 | 64.67M |
| December 31, 2021 | 65.49M |
| September 30, 2021 | 63.52M |
| June 30, 2021 | 72.91M |
| March 31, 2021 | 69.67M |
| December 31, 2020 | 78.91M |
| Date | Value |
|---|---|
| September 30, 2020 | 87.55M |
| June 30, 2020 | 80.15M |
| March 31, 2020 | 45.24M |
| December 31, 2019 | 54.58M |
| September 30, 2019 | 27.02M |
| June 30, 2019 | 20.28M |
| March 31, 2019 | 24.74M |
| December 31, 2018 | 33.97M |
| September 30, 2018 | 39.40M |
| June 30, 2018 | 49.23M |
| March 31, 2018 | 55.24M |
| December 31, 2017 | 61.61M |
| September 30, 2017 | 4.381M |
| June 30, 2017 | 8.662M |
| December 31, 2016 | 15.17M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
21.62M
Minimum
Jun 2024
87.55M
Maximum
Sep 2020
55.84M
Average
57.39M
Median
Shareholders Equity (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 5.413B |
| Arbutus Biopharma Corp | 106.89M |
| GlycoMimetics Inc | 11.38M |
| FibroGen Inc | -243.67M |
| Cidara Therapeutics Inc | 115.63M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 44.81M |
| Total Liabilities (Quarterly) | 19.44M |
| Debt to Equity Ratio | 0.2086 |
| Current Ratio | 2.219 |
| Net Debt Paydown Yield | 2.10% |